SCHEMBL91179

SCHEMBL91179

CC1(C(=O)O)CC=CCC1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.50
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2417620 1.00 FFAR3 (0.50) FFAR3CYP3A4
SCHEMBL2126984 0.87 FFAR3 (0.39) FFAR3
SCHEMBL29777439 0.85 FFAR3 (0.39) FFAR3
SCHEMBL3864826 0.83
SCHEMBL28485190 0.82 FFAR3 (0.33) FFAR3
SCHEMBL6226191 0.80 FFAR3 (0.32) FFAR3
SCHEMBL2128101 0.80 PKM (0.32) FFAR3
SCHEMBL23748631 0.80 FFAR3 (0.54) FFAR3
SCHEMBL15740999 0.80 FFAR3 (0.54) FFAR3
SCHEMBL23748594 0.80 FFAR3 (0.54) FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12123029-B2 Cyclohexenecarboxylate ester hydrolase, and mutant, coding gene, expression vector, recombinant bacterium and use thereof JIANGNAN UNIVERSITY (CN) 2024-10-22 US claimed
EP-3368539-A1 SUBSTITUTED INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF Merck Sharp & Dohme Corp. (US) 2018-09-05 EP claimed
WO-2017075182-A1 SUBSTITUTED INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2017-05-04 WO claimed
WO-2024068235-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2024-04-04 WO disclosed
WO-2024068234-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2024-04-04 WO disclosed
WO-2023170176-A1 EMULSIONS AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2023-09-14 WO disclosed
WO-2023170156-A1 BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2023-09-14 WO disclosed
WO-2023170158-A1 BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION XAMPLA LIMITED (GB) 2023-09-14 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-3427738-B1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMA (US) 2021-12-01 EP disclosed
EP-3888782-A1 COATED MICROCAPSULES Noxell Corporation (US) 2021-10-06 EP disclosed
US-5840647-A Hydroformylation process using novel phosphite-metal catalyst system EASTMAN CHEMICAL COMPANY (US) 1998-11-24 US disclosed
EP-0627439-A1 Hydroformylation process using novel phosphine-rhodium catalyst system EASTMAN CHEMICAL COMPANY (US) 1994-12-07 EP disclosed
US-5344988-A Hydroformylation process using novel phosphine-rhodium catalyst system EASTMAN CHEMICAL COMPANY (US) 1994-09-06 US disclosed
US-5332846-A Hydroformylation process using novel phosphine-rhodium catalyst system EASTMAN KODAK COMPANY (US) 1994-07-26 US disclosed
EP-0096890-B1 OXAZOLEACETIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING SAID DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 1987-11-25 EP disclosed
US-4602027-A HYPOGLYCEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-07-22 US disclosed
US-4461902-A BLOOD LIPID AND SUGAR LOWERING AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1984-07-24 US disclosed
EP-0096890-A2 Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives Takeda Chemical Industries, Ltd. (JP) 1983-12-28 EP disclosed
EP-0084926-A1 Thiazolidine derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1983-08-03 EP disclosed